Inventor · disambiguated record
Andreas Maderna
Also filed as: MADERNA ANDREAS · MADERNA ANDREAS LOTHAR SEVERINO
29 granted patents·11 pending applications·224 citations·filing 2000–2024
96Inventor score
Top patents by PatentIndex Score
40 records- 0195US7820664B2Inhibitors of MEKARDEA BIOSCIENCES INC·Filed 2008·Granted Oct 26, 2010·37 cites·59 claims
- 0294US8828401B2Cytotoxic peptides and antibody drug conjugates thereofPFIZER·Filed 2012·Granted Sep 9, 2014·35 cites·36 claims
- 0394US7759518B2Derivatives of N-(arylamino) sulfonamides as inhibitors of MEKARDEA BIOSCIENCES·Filed 2008·Granted Jul 20, 2010·41 cites·4 claims
- 0492US11744876B2Immunomodulator antibody drug conjugates and uses thereofSUTRO BIOPHARMA INC·Filed 2020·Granted Sep 5, 2023·4 cites·47 claims
- 0592US8101799B2Derivatives of N-(arylamino) sulfonamides as inhibitors of MEKMADERNA ANDREAS·Filed 2007·Granted Jan 24, 2012·28 cites·77 claims
- 0690US10538542B2Cyclopentane-based modulators of STING (stimulator of interferon genes)PFIZER·Filed 2019·Granted Jan 21, 2020·4 cites·38 claims
- 0790US8063049B2Inhibitors of MEKKOH YUNG-HYO·Filed 2010·Granted Nov 22, 2011·24 cites·20 claims
- 0889US8513443B2Preparation of (R)-N-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide and (S)-N-3,4-difluoro-2(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamideMADERNA ANDREAS·Filed 2010·Granted Aug 20, 2013·4 cites·4 claims
- 0988US9249186B2Cytotoxic peptides and antibody drug conjugates thereofPFIZER·Filed 2015·Granted Feb 2, 2016·7 cites·5 claims
- 1087US7429667B2Phenylamino isothiazole carboxamidines as MEK inhibitorsARDEA BIOSCIENCES INC·Filed 2006·Granted Sep 30, 2008·7 cites·13 claims
- 1186US10662204B2Substituted quinazoline and pyridopyrimidine derivatives useful as anticancer agentsPFIZER·Filed 2019·Granted May 26, 2020·4 cites·21 claims
- 1285US9138486B2Cytotoxic peptides and antibody drug conjugates thereofPFIZER·Filed 2014·Granted Sep 22, 2015·7 cites·29 claims
- 1385US8884058B2Preparation of (R)-N-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide and (S)-N-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamideARDEA BIOSCIENCES INC·Filed 2013·Granted Nov 11, 2014·2 cites·8 claims
- 1484US2023382932A1Cyclopentane-Based Modulators of STING (Stimulator of Interferon Genes)PFIZER·Filed 2023·Application pending·0 cites
- 1583US10968242B2Cyclopentane-based modulators of STING (stimulator of interferon genes)PFIZER·Filed 2019·Granted Apr 6, 2021·1 cites·6 claims
- 1683US7652047B2Phenylamino isothiazole carboxamidines as MEK inhibitorsARDEA BIOSCIENCES INC·Filed 2008·Granted Jan 26, 2010·4 cites·27 claims
- 1780US10590115B2Tetrahydroquinazoline derivatives useful as anticancer agentsPFIZER·Filed 2019·Granted Mar 17, 2020·2 cites·14 claims
- 1877US12144869B2Anti-ROR1 antibody conjugates, compositions comprising anti ROR1 antibody conjugates, and methods of making and using anti-ROR1 antibody conjugatesSUTRO BIOPHARMA INC·Filed 2023·Granted Nov 19, 2024·0 cites·24 claims
- 1977US2025135025A1Anti-ror1 antibody conjugates, compositions comprising anti ror1 antibody conjugates, and methods of making and using anti-ror1 antibody conjugatesSTURO BIOPHARMA INC·Filed 2024·Application pending·0 cites
- 2077US2025018054A1Anti-ror1 antibody conjugates, compositions comprising anti ror1 antibody conjugates, and methods of making and using anti-ror1 antibody conjugatesSUTRO BIOPHARMA INC·Filed 2024·Application pending·0 cites
- 2176US6664426B1Ether and ester derivatives of the perborate icosahedronUNIV CALIFORNIA·Filed 2000·Granted Dec 16, 2003·9 cites·5 claims
- 2275US12226490B2Anti-ROR1 antibody conjugates, compositions comprising anti ROR1 antibody conjugates, and methods of making and using anti-ROR1 antibody conjugates preliminary classSUTRO BIOPHARMA INC·Filed 2023·Granted Feb 18, 2025·0 cites·38 claims
- 2373US10086085B2Bifunctional cytotoxic agentsPFIZER·Filed 2015·Granted Oct 2, 2018·2 cites·13 claims
- 2470US2021230196A1Cyclopentane-Based Modulators of STING (Stimulator of Interferon Genes)PFIZER·Filed 2021·Application pending·0 cites
- 2569US8829052B2Derivatives of N-(arylamino)sulfonamides as inhibitors of MEKMADERNA ANDREAS·Filed 2011·Granted Sep 9, 2014·1 cites·23 claims
- 2669US2024139285A1Immunomodulator antibody drug conjugates and uses thereofSUTRO BIOPHARMA INC·Filed 2023·Application pending·0 cites
- 2768US9873690B23-indol substituted derivatives, pharmaceutical compositions and methods for usePFIZER·Filed 2016·Granted Jan 23, 2018·1 cites·9 claims
- 2868US9296686B2Preparation of (R)-N-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide and (S)-N-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamideARDEA BIOSCIENCES INC·Filed 2014·Granted Mar 29, 2016·0 cites·8 claims
- 2965US12178876B2Conjugates comprising cleavable linkersASTRAZENECA AB·Filed 2024·Granted Dec 31, 2024·0 cites·24 claims
- 3063US12337038B2Conjugates comprising cleavable beta-glucuronide-containing linkersASTRAZENECA AB·Filed 2024·Granted Jun 24, 2025·0 cites·26 claims
- 3161US11365263B2Bifunctional cytotoxic agents containing the CTI pharmacophorePFIZER·Filed 2020·Granted Jun 21, 2022·0 cites·4 claims
- 3261US2024091365A1Beta-glucuronide linker-payloads, protein conjugates thereof, and methods thereofSUTRO BIOPHARMA INC·Filed 2023·Application pending·0 cites
- 3361US2025361253A1Sting agonist compoundsSUTRO BIOPHARMA INC·Filed 2023·Application pending·0 cites
- 3460US2025041435A1Steap2 antibody drug conjugates and uses thereofMEDIMMUNE LLC·Filed 2024·Application pending·0 cites
- 3559US2014378466A1Derivatives of n-(arylamino) sulfonamides as inhibitors of mekARDEA BIOSCIENCES·Filed 2014·Application pending·0 cites
- 3654US10870706B2Bifunctional cytotoxic agents containing the CTI pharmacophorePFIZER·Filed 2016·Granted Dec 22, 2020·0 cites·19 claims
- 3754US2017183333A1Derivatives of n-(arylamino) sulfonamides as inhibitors of mekARDEA BIOSCIENCES INC·Filed 2016·Application pending·0 cites
- 3849US2008293712A1Benzo[C][2,7]Naphtyridine Derivatives, Methods of Making Thereof and Methods of Use ThereofWYETH CORP·Filed 2008·Application pending·0 cites
- 3948US10391182B2Bifunctional cytotoxic agentsPFIZER·Filed 2018·Granted Aug 27, 2019·0 cites·8 claims
- 4038US10544095B23-indol substituted derivatives, pharmaceutical compositions and methods for usePFIZER·Filed 2016·Granted Jan 28, 2020·0 cites·7 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →